ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGN Argenica Therapeutics Limited

0.675
0.035 (5.47%)
Mar 04 2024 - Closed
Delayed by 20 minutes

Argenica Therapeutics Financial Summary

The current AGN market cap is 67.16M. The company's latest EPS is AUD -0.0484 and P/E is -13.84.

Year End June 29 2023 20202020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 00296k259k1.75M
Operating Income -383k0-614k-4.09M-4.88M
Net Income -383k0-1.03M-4.09M-4.82M
Year End June 29 2023 20202020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 378k7.52M7.27M9.04M9.54M
Total Liabilities 359k58k426k736k1.88M
Total Equity 19k7.46M6.85M8.31M7.67M

Cash Flow

Year End June 29 2023 20202020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating -59k N/A -1.05M-3.36M-3.3M
Investing N/A N/A N/A N/A -50k
Financing 401k N/A 7.85M5.13M3.73M
Market Cap 67.16M
Price to Earnings Ratio -13.84
Price to Sales Ratio 38.07
Price to Cash Ratio 7.17
Price to Book Ratio 8.7
Dividend Yield -

Share Statistics

Shares Outstanding 99.5M
Average Volume (1 week) 155.69k
Average Volume (1 Month) 111.15k
52 Week Change 50.00%
52 Week High 0.75
52 Week Low 0.295
Spread (Intraday) 0.04 (5.04%)

Company Info

Company Name Argenica Therapeutics Limited
Address unit 4
nedlands, western australia 6009
Website https://
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock